Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
J Infect Dis. 2011 Jul;204 Suppl 1:S549-58. doi: 10.1093/infdis/jir106.
Waning immunity or secondary vaccine failure (SVF) has been anticipated by some as a challenge to global measles elimination efforts. Although such cases are infrequent, measles virus (MeV) infection can occur in vaccinated individuals following intense and/or prolonged exposure to an infected individual and may present as a modified illness that is unrecognizable as measles outside of the context of a measles outbreak. The immunoglobulin M response in previously vaccinated individuals may be nominal or fleeting, and viral replication may be limited. As global elimination proceeds, additional methods for confirming modified measles cases may be needed to understand whether SVF cases contribute to continued measles virus (MeV) transmission. In this report, we describe clinical symptoms and laboratory results for unvaccinated individuals with acute measles and individuals with SVF identified during MeV outbreaks. SVF cases were characterized by the serological parameters of high-avidity antibodies and distinctively high levels of neutralizing antibody. These parameters may represent useful biomarkers for classification of SVF cases that previously could not be confirmed as such using routine laboratory diagnostic techniques.
免疫减弱或二次疫苗失效(SVF)被一些人认为是全球麻疹消除工作面临的挑战。虽然这种情况并不常见,但在接种疫苗的个体受到强烈和/或长时间接触感染者后,仍可能发生麻疹病毒(MeV)感染,并且可能表现为一种在麻疹爆发情况下才被识别为麻疹的改变后的疾病。在先前接种疫苗的个体中,免疫球蛋白 M 的反应可能微不足道或短暂,病毒复制可能受到限制。随着全球消除工作的推进,可能需要额外的方法来确认改良型麻疹病例,以了解 SVF 病例是否有助于持续的麻疹病毒(MeV)传播。在本报告中,我们描述了急性麻疹未接种疫苗的个体以及 MeV 爆发期间确定的 SVF 个体的临床症状和实验室结果。SVF 病例的特征是具有高亲和力抗体和明显高水平中和抗体的血清学参数。这些参数可能代表用于 SVF 病例分类的有用生物标志物,此前使用常规实验室诊断技术无法对此类病例进行确认。